IP Library Granted Patent US 8,759,115
Granted Patent B2
US 8,759,115 · App. 13/712,230 · Granted Jun 24, 2014

Assay device

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,759,115
App. No.
13/712,230
Granted
Jun 24, 2014
Kind
B2
Abstract

An assay device for performing an assay on a liquid sample using a detection conjugate capable of binding to an antigen and containing a label. The device includes a substrate surface having a sample addition zone, a reaction zone and an absorbing zone, the zones being connected by at least one fluid passage, wherein the device has a first functionality verifying feature located between the sample addition zone and the reaction zone, and a second functionality verifying feature located within the absorbing zone. Both functionality verifying features are capable of undergoing a detectable change when contacted by the sample, in which the assay device further includes at least one alignment verification zone. There is further provided a kit of parts and a method of conducting an assay.

Claims (16)

1. A method of conducting an assay, comprising:

verifying the alignment of an assay device in a reader using at least one alignment verification zone disposed on the assay device;

adding a sample and detecting at least one reaction between the sample and one or more reagents using the assay device, the assay device having at least one fluid passage, a sample addition zone, a reaction zone and an absorbing zone, said one or more reagents including a detection conjugate capable of binding to an antigen and containing a label;

determining the presence of the label in a first area downstream from the sample addition zone in which the absence of signal or detection of an insufficient signal is taken as an indication of error;

said method further comprising a calibration step, wherein the amount of at least one label, pre-dispensed in a zone for calibration on the assay device, separate from the fluid passage, is determined and the amount compared to a preset value.

2. The method according to claim 1 , the reader including a display, the method further comprising:

displaying an error message without delay, including prompting a user to remove the assay device from the reader and attempt a new assay.

3. The method according to claim 1 , wherein the result of the analysis is adjusted based on the result of the calibration step.

4. The method according to claim 3 , the reader including a display, the method further comprising:

displaying a margin of error, based on the result of said calibration step to a user together with the result of the analysis.

5. The method according to claim 1 , wherein said predispensed label is the same label used in said detection conjugate.

6. The method according to claim 1 , further comprising:

using the reader, determining the amount of detection conjugate which has passed the reaction zone based on the amount of label detected.

7. The method according to claim 1 , wherein the kinetics of the reaction are determined based on the amount of detection conjugate determined over a range of time.

8. The method according to claim 1 , further comprising:

measuring the progression of the mixture of the sample and detection conjugate and recording the kinetics of the conjugate transport.

Assignments (9)
SECURITY AGREEMENT Recorded Aug 22, 2025
From: CRIMSON INTERNATIONAL ASSETS LLC; MICRO TYPING SYSTEMS, INC.; ORTHO-CLINICAL DIAGNOSTICS, INC.; QUIDEL CARDIOVASCULAR INC.
To: BANK OF AMERICA, N.A., AS ADMINISTRATIVE AGENT
Reel/Frame 072526/0643 →
RELEASE (REEL 060220 / FRAME 0711) Recorded Aug 22, 2025
From: BANK OF AMERICA, N.A.
To: QUIDEL CORPORATION; BIOHELIX CORPORATION; DIAGNOSTIC HYBRIDS, INC.; QUIDEL CARDIOVASCULAR INC.; ORTHO-CLINICAL DIAGNOSTICS, INC.; CRIMSON U.S. ASSETS LLC; CRIMSON INTERNATIONAL ASSETS LLC; MICRO TYPING SYSTEMS, INC.
Reel/Frame 072577/0536 →
SECURITY AGREEMENT Recorded May 31, 2022
From: QUIDEL CORPORATION; BIOHELIX CORPORATION; DIAGNOSTIC HYBRIDS, INC.; QUIDEL CARDIOVASCULAR INC.; ORTHO-CLINICAL DIAGNOSTICS, INC.; CRIMSON U.S. ASSETS LLC; CRIMSON INTERNATIONAL ASSETS LLC; MICRO TYPING SYSTEMS, INC.
To: BANK OF AMERICA, N.A.
Reel/Frame 060220/0711 →
RELEASE OF SECURITY INTEREST Recorded May 31, 2022
From: BANK OF AMERICA, N.A.
To: ORTHO-CLINICAL DIAGNOSTICS, INC.; CRIMSON U.S. ASSETS LLC; CRIMSON INTERNATIONAL ASSETS LLC
Reel/Frame 060219/0571 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 20, 2018
From: OHMAN, PER OVE; MENDEL-HARTVIG, IB; LINDSTROM, TOMAS
To: AMIC AB
Reel/Frame 047554/0062 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 13, 2018
From: JOHNSON & JOHNSON AB
To: CRIMSON INTERNATIONAL ASSETS LLC
Reel/Frame 046773/0588 →
SECURITY INTEREST Recorded Jul 3, 2014
From: ORTHO-CLINICAL DIAGNOSTICS, INC; CRIMSON U.S. ASSETS LLC; CRIMSON INTERNATIONAL ASSETS LLC
To: BARCLAYS BANK PLC, AS COLLATERAL AGENT
Reel/Frame 033276/0104 →
MERGER Recorded Mar 20, 2014
From: AMIC AB
To: JOHNSON & JOHNSON AB
Reel/Frame 032487/0202 →
MERGER Recorded Dec 31, 2013
From: AMIC AB
To: JOHNSON & JOHNSON AB
Reel/Frame 031861/0986 →